Clinical trials: Diabetes Melletus, Type 1
Diabetes, Diabetes Melletus, Type 1
ROME GS System Study
The purpose of this clinical investigation is to demonstrate that the proposed physical changes to the ROME GS Sensor do not have any adverse impact on safety and performance when compared to the Eversense 365 Sensor.
- Conditions
- Diabetes, Diabetes Melletus, Type 1, Diabetes Mellitus, Type 2
- Trial name
- NCT07518004
- Testing
- Continuous Glucose Monitoring System
- Where
- 4 sites in United States
- Volunteers
- 60 people
- Sponsor
- Senseonics, Inc.